Impact of pharmacist intervention in patients with Alzheimer's disease

• Autor(a) principal: Forgerini, Marcela [UNESP]
• Data de Publicação: 2022
• Outros Autores: Lucchetta, Rosa Camila, Oliveira, Fernanda Mariana [UNESP], Herdeiro, Maria Teresa, Capela, Marisa Veiga [UNESP], Mastroianni, Patricia de Carvalho [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• DOI: 10.1590/s2175-97902022e19876
• Texto Completo: http://dx.doi.org/10.1590/s2175-97902022e19876; http://hdl.handle.net/11449/237817
• topic: Elderly; Face-to-face; Medication adherence; Medication errors; Medication review

To assess the therapy relative to indication, effectiveness, safety and adherence in patients with Alzheimer's disease (AD). An interventional, prospective, non-randomized study was conducted in a single secondary care center in Brazil. The pharmacist-led Medication Therapy Management (MTM) was conducted to detect drug-related problems (DRPs) at baseline and after six months of intervention. The health status outcomes (i.e. cognitive screening tests; levels of glucose; total cholesterol; triglycerides; thyroid stimulating hormone; serum free thyroxine; and blood pressure) were measured. 66 patients with AD were included, of whom 55 patients completed the follow-up of six months. 36 patients (36/55) were non-adherent to AD drug therapy. Out of detected 166 DRPs, 116 were solved. Four patients were withdrawn from the AD protocol due to resolution of prodromal symptoms. On the conclusion of the study, the MTM improved and controlled blood pressure, glucose, total cholesterol and triglycerides levels (p<0.05). The pharmacist-led MTM was effective in solving 69.8% of DRPs, improving and controlling the clinical parameters evaluated.